Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03737981 |
|---|---|
| Brief Title: | Testing The Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia |
| First Submitted : | November 9, 2018 |
| First Submitted that Met QC Criteria : | November 9, 2018 |
| First Posted : | November 13, 2018 |
| Last Update Submitted that Met QC Criteria : | April 3, 2024 |
| Last Update Posted : | April 4, 2024 |